XERIS BIOPHARMA HOLDINGS INC XERS 8 07.15.28
NOTE 8.000% 7/1 · US DOMESTIC · CUSIP 98422EAB9
3
institutional holders
-1 vs Q1 2025
$33.6mprincipal reported held*
$56.9mreported value*
0 new
1 added
0 reduced
1 sold out
net bought ≈ $0
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2025 | 4 |
| Q2 2025 | 3 |
Biggest buyers
| CAPSTONE INVESTMENT ADVISORS, LLC | Added | +2.2m |
Biggest sellers
| Sessa Capital IM, L.P. | Sold out | -2.2m |
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| CAPSTONE INVESTMENT ADVISORS, LLC 0.33% of their portfolio | 23.1m $39.2m | Added +2.2m |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.32% of their portfolio | 10.5m $17.7m | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |